The effect of targeted treatment on people with patellofemoral pain: A pragmatic, randomised controlled feasibility study

Health Education Employment Social Security Welfare Veterans

21 p | 46 | 2

Optimal sequencing of the first-and second-line target therapies in metastatic renal cell carcinoma: Based on nationally representative data analysis from the Korean National Health Insurance System

13 p | 5 | 2

Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells

12 p | 10 | 2

Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: A retrospective cross-sectional analysis

11 p | 19 | 2

Delay in DOTS for new pulmonary tuberculosis patient from rural area of Wardha District, India

7 p | 50 | 2

The effects of combination treatments on drug resistance in chronic myeloid leukaemia: An evaluation of the tyrosine kinase inhibitors axitinib and asciminib

14 p | 14 | 1

The combined effect of dichloroacetate and 3-bromopyruvate on glucose metabolism in colorectal cancer cell line, HT-29; the mitochondrial pathway apoptosis

11 p | 7 | 1

The structural effect of high intensity ultrasound on peritoneal tissue: A potential vehicle for targeting peritoneal metastases

7 p | 18 | 0

Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma

9 p | 18 | 0